SPONSOR

Yale University

Total Trials

Recruiting

Phases

Phase 1, Phase 4, Phase 2, Phase 1, Phase 2, Phase 3

Conditions studied: Cannabis Autism Spectrum Disorder Glioma Glioma Surgery Heart Failure Palliative Care Femoral Arterial Calcification Peripheral Arterial Disease Claudication Critical Limb Ischemia

Yale University is a clinical research sponsor with 32 registered studies on ClinicalTrials.gov, of which 32 are actively recruiting participants. Research covers conditions including Cannabis, Autism Spectrum Disorder, Glioma, Glioma Surgery.

The trial portfolio spans Phase 1, Phase 4, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Yale University

How many clinical trials has Yale University sponsored?

ClinicalMetric currently tracks 32 clinical trials sponsored by Yale University, of which 32 are actively recruiting participants. These trials cover conditions including Cannabis, Autism Spectrum Disorder, Glioma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Yale University research focus on?

Yale University clinical trials span Cannabis, Autism Spectrum Disorder, Glioma, Glioma Surgery, Heart Failure, and additional conditions. The research pipeline includes Phase 1, Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Yale University clinical trial?

To participate in a Yale University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Yale University trials with current recruitment status updated daily.

Yale University

Frequently Asked Questions — Yale University

Clinical Trials by Yale University

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I

Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)

Language Network Prehab Via fMRI Neurofeedback

Promoting Palliative Care for People With Heart Failure

CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions

Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda

Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer

LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes

Adaptation and Implementation of Peer Support in Brazil

fMRI and Opioid Abstinence

The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry

Investigation of Lymph Node Biology in Kidney Cancer

Efficacy of Guselkumab in Treating Hailey Hailey Disease

A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure

Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA

Operative Versus Non-Operative Management for Appendicitis With Abscess or Phlegmon

Implementing Suicide Prevention Into Primary Care in Nepal

The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)

AMPK-activation by Metformin in FSGS: AMP-FSGS

The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

The Recovery in Stroke Using PAP Study

Unified Network for Integrated Fluid Collection at Yale

Emergency Department-Initiated Medications for Alcohol Use Disorder

Speech Motor Learning and Retention (Aim 1)

Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers

Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

Integrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics

Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes